A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections | Zendy

Gary J. Noel | Zendy; Karen Bush | Zendy; Partha Bagchi | Zendy; Juliana Ianus | Zendy; Richard Strauß | Zendy

Open Access

A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections

Author(s) -

Gary J. Noel,

Karen Bush,

Partha Bagchi,

Juliana Ianus,

Richard Strauß

Publication year - 2008

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/526527

Subject(s) - medicine , ceftazidime , vancomycin , cellulitis , population , randomized controlled trial , surgery , clinical trial , staphylococcus aureus , pseudomonas aeruginosa , genetics , environmental health , bacteria , biology

A randomized, double-blind, multicenter trial involving patients with a broad range of complicated skin and skin-structure infections due to either gram-positive or gram-negative bacteria was conducted to compare ceftobiprole monotherapy with treatment with vancomycin plus ceftazidime.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research